Although IL-6 elevation would not likely be specific to HD compared to other neurodegenerative diseases, the advent of an effective, dependable salivary biomarker would meet the urgent need for a less invasive means of identifying and monitoring HD disease progression. The gene discussed is IL6; the disease is neurodegenerative disease.